Pricing analyses

Companies often have little knowledge of the potential economic impact of new therapies; in the current environment, such information is critical to development planning, commercial assessment, and pricing. PAI pioneered the development of pharmacoeconomic models for use in forecasting the expected impact of new products on total costs of care.